Recherche Images Maps Play YouTube Actualités Gmail Drive Plus »
Recherche avancée dans les brevets | Historique Web | Connexion

Brevets

Référencé par

Brevet citant Date de dépôt Date de délivrance Cessionnaire d'origine Titre
US399442129 sept. 197530 nov. 1976American Cyanamid CompanyUnitary therapeutic aerosol dispenser
US399822622 sept. 197521 déc. 1976Edward G. GomezInhalation device for encapsulated concentrates
US411461510 déc. 197619 sept. 1978Aktiebolaget DracoAerosol inhalation device
US504052718 déc. 199020 août 1991Healthscan Products Inc.Metered dose inhalation unit with slide means
US507429421 juin 198924 déc. 1991Chiesi Farmaceutici S.p.A.Device for dispensing metered amounts of aerosol for inhalation
US518616415 mars 199116 févr. 1993Mist inhaler
US559883626 mai 19954 févr. 1997Healthscan Products, Inc.Metered dose inhalation unit with slide means
US565396219 mai 19955 août 1997Glaxo Group LimitedAerosol formulations containing P134a and particulate medicaments
US565854919 mai 199519 août 1997Glaxo Group LimitedAerosol formulations containing propellant 134a and fluticasone propionate
US567447119 mai 19957 oct. 1997Glaxo Group LimitedAerosol formulations containing P134a and salbutamol
US567447219 mai 19957 oct. 1997Glaxo Group LimitedCanisters containing aerosol formulations containing P134a and fluticasone propionate
US567692919 mai 199514 oct. 1997Glaxo Group LimitedCanister containing aerosol formulations containing P134a and particulate medicaments
US568367619 mai 19954 nov. 1997Glaxo Group LimitedCanister containing aerosol formulations containing P134a and particulate medicaments
US573612430 mai 19957 avr. 1998Glaxo Group LimitedAerosol formulations containing P134a and particulate medicament
US57441235 juin 199528 avr. 1998Glaxo Group LimitedAerosol formulations containing P134a and particulate medicaments
US581729330 mai 19956 oct. 1998Glaxo Group LimitedCanister containing aerosol formulations containing P134a and particulate medicaments
US583942920 août 199724 nov. 1998Astra AktiebolagMethod and apparatus in connection with an inhaler
US59165406 avr. 199829 juin 1999Glaxo Group LimitedAerosol formulations containing P134A and/or P227 and particulate medicament
US592230615 avr. 199813 juil. 1999Glaxo Group LimitedAerosol formulations containing P134a and particulate medicament
US59765733 juil. 19962 nov. 1999Rorer Pharmaceutical Products Inc.Aqueous-based pharmaceutical composition
US59938057 juin 199530 nov. 1999Quadrant Healthcare (UK) LimitedSpray-dried microparticles and their use as therapeutic vehicles
US614332920 mai 19997 nov. 2000Rorer Pharmaceutical Products Inc.Aqueous-based pharmaceutical composition
US62005499 mars 199913 mars 2001Glaxo Group LimitedAerosol formulation containing P134a and particulate medicament
US622133910 mai 199924 avr. 2001Glaxo Group LimitedMedicaments
US62386472 nov. 199929 mai 2001Glaxo Group LimitedAerosol formulations containing salmeterol xinafoate, an anticholinergic agent and tetrafluoroethane
US625136817 juin 199726 juin 2001Glaxo Group LimitedPharmaceutical aerosol formulation containing a particulate medicament, a propellant and substantially free of a surfactant
US62932797 avr. 199925 sept. 2001Trudell Medical InternationalAerosol medication delivery apparatus and system
US630310314 juin 200016 oct. 2001Glaxo Group LimitedAerosols containing salmeterol xinafoate and an anticholinergic medicament
US630636928 avr. 200023 oct. 2001Glaxo Group LimitedAerosol formulations containing P134a and particulate medicament
US63330231 mai 200025 déc. 2001Glaxo Group LimitedAerosol formulation containing particulate formoterol, propellant and polar cosolvent
US634561726 sept. 199712 févr. 20021263152 Ontario Inc.Aerosol medication delivery apparatus and system
US643517715 août 200120 août 2002Trudell Medical InternationalAerosol medication delivery apparatus and system
US670965025 août 199923 mars 2004Elam Drug Delivery LimitedSpray-dried microparticles and their use as therapeutic vehicles
US674341331 mai 19951 juin 20043M CompanySuspension aerosol formulations
US689362831 mars 200317 mai 2005Glaxo Group LimitedAerosol formulations containing P134a and particulate medicament
US691906930 avr. 200319 juil. 2005Glaxo Group LimitedAerosol formulation containing particulate formoterol, propellant and polar cosolvent
US702505826 avr. 200211 avr. 2006New England Pharmaceuticals, Inc.Metered dose delivery device for liquid and powder agents
US710153431 mai 19955 sept. 20063M Innovative Properties CompanySuspension aerosol formulations
US710515231 mai 199512 sept. 20063M Innovative Properties CompanySuspension aerosol formulations
US749802023 nov. 20043 mars 2009Glaxo Group LimitedMedicaments
US756265617 sept. 200421 juil. 2009Hydrate, Inc.Aerosol medication inhalation system
US758228414 avr. 20031 sept. 2009Nektar TherapeuticsParticulate materials
US797704522 mars 201012 juil. 2011Aventis Pharmaceuticals Inc.Aqueous-based pharmaceutical composition
US799419726 août 20099 août 2011MAP Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US807464111 déc. 200813 déc. 2011Pre Holdings, Inc.Aerosol medication inhalation system
US808023612 juin 200920 déc. 2011Nektar Therapeutics UK, LtdParticulate materials
US811963919 juil. 201021 févr. 2012MAP Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
US812376114 oct. 200528 févr. 2012Meda ABDevice for removing a tick
US813765716 mai 200320 mars 2012Vectura LimitedCarrier particles for use in dry powder inhalers
US814837711 févr. 20083 avr. 2012MAP Pharmaceuticals, Inc.Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
USRE4317418 janv. 200714 févr. 2012Trudell Medical InternationalAerosol delivery apparatus

Dessins